Hana Pharm Co., Ltd. (293480.KS) KSC
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 199.41B |
| Enterprise Value | 248.29B |
| P/E Ratio | 8.56 |
| PEG Ratio | -0.58 |
| Price/Sales Ratio | 0.6 |
| Price/Book Ratio | 0.45 |
| Enterprise/Revenue | 0.83 |
| Enterprise/EBITDA | 4.94 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.07 |
| Operating Margin | 0.12 |
AD
Management Effectiveness
| Return On Assets | 0.04 |
| Return On Equity | 0.05 |
Income Statement
| Revenue | 239.5B |
| Revenue/Share | 13,954.31 |
| Gross Profit | 146.39B |
| EBITDA | 36.95B |
| Net Income | 8.78B |
| Diluted EPS | 507 |
Balance Sheet
| Total Cash | 17.28B |
| Total Cash/Share | 975.28 |
| Total Debt | 68.84B |
| Total Debt/Equity | 0.21 |
| Current Ratio | 1.96 |
| Book Value Per Share | 18,718.75 |
Price History
| 52-Week Change | -27.31 |
| 52-Week High | 12,390 |
| 52-Week Low | 8,120 |
| Moving Average 50 Days | 8,712.6 |
| Moving Average 200 Days | 9,944.9 |
Statistics
| Average Volume | 36,314 |
| Shares Outstanding | 17.72M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 260 |
| Trailing Annual Dividend Yield | 3.09 |
| Payout Ratio | 0.26 |
| Last Split Factor | 11:10 |
| Last Split Date | April 28, 2021 |
AD
